BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

BIOLASE, Inc.

BIOLASE provides dental lasers and related education and training services, focusing on minimally invasive solutions in dentistry. The company is self-described as a leader in dental laser technology.

msh id	COM:BIOLASE
symbol	BIOL
name	BIOLASE, Inc.
homepage url	https://www.biolase.com
country	US
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	157
crunchbase url	-
linkedin url	-
founders	-

market cap	2.84M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-0.09
growth cost of revenue	-0
growth depreciation and amortization	4.63
growth ebitda	0.39
growth ebitda ratio	0.4
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-0.17
growth gross profit	0.05
growth gross profit ratio	0.04

COM:BIOLASE

BIOLASE

Last Close

0.02

02/10 20:00

Market Cap

2.84M

Beta: -

Volume Today

2.67M

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	67.1M
cost of revenue	67.1M
depreciation and amortization	2.8M
ebitda	-15.14M
ebitda ratio	-0.31
eps	-16.14
eps diluted	-16.14
operating expenses	34.66M
operating income	-17.94M
operating income ratio	-0.36

accounts receivables	201K
capital expenditure	-1.31M
cash at beginning of period	4.18M
cash at end of period	6.57M
inventory	11.43M
working capital ttm	8M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-